Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Pruritus Drugs Market Outlook

The global pruritus drugs market is expected to grow at a CAGR of 5.4% in the forecast period of 2024-2032 to reach USD 5.49 billion by 2032.

Global Pruritus Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The industry is being driven by the expansion of nanoparticle-enabled transdermal drug delivery systems. North America is anticipated to hold the largest share in the market during the forecast period owing to the increasing prevalence of hematologic diseases.

Market Segmentation

Pruritus is a non-fatal condition caused due to the use of immunotherapy - the immune responses to toxins released from cancerous cells. The rising adoption of immunotherapy can increase the risk of pruritus, hence, leading to an increased demand for pruritus drugs. The major application areas for the product include hematologic pruritus, oncological pruritus, renal pruritus, endocrine pruritus, and cholestatic pruritus.

Global Pruritus Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The EMR report looks into the regional pruritus drugs markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

Market Analysis

The global pruritus drugs market is boosted by the increasing adoption of immunotherapy and the advancement in nanoparticle-enabled transdermal drug delivery systems. The hematologic pruritus segment accounted for the largest industry share in 2020, however, the oncological pruritus segment is expected to lead the industry during the forecast period due to factors such as increasing prevalence of cancer and the growth in the study of oncology. North America is anticipated to account for the largest share in the market as a result of rising cancer incidences, growth in the percentage of the older population, and increased market penetration of pharmaceutical suppliers.

Global Pruritus Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

The report presents a detailed analysis of the following key players in the global pruritus drugs market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Johnson & Johnson Consumer Inc. 
  • Pfizer Inc.
  • AbbVie Inc. 
  • Astellas Pharma Inc.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Application
  • Region
Breakup by Application
  • Hematologic pruritus
  • Oncological pruritus
  • Renal pruritus
  • Endocrine pruritus
  • Cholestatic pruritus
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Johnson & Johnson Consumer Inc. 
  • Pfizer Inc.
  • AbbVie Inc. 
  • Astellas Pharma Inc.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 5.4% between 2024 and 2032.

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 5.49 billion by 2032.

The major industry drivers in the market are rising urbanisation and industrialisation, expansion of nanoparticle-enabled transdermal drug delivery systems, and increasing prevalence of hematologic diseases.

The key trends in the market are increasing adoption of immunotherapy and advancements in technology.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share in the market.

Hematologic pruritus is the dominant application segment in the industry.

The major players in the industry are Johnson & Johnson Consumer Inc., Pfizer Inc., AbbVie Inc., and Astellas Pharma Inc., among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124